Profile data is unavailable for this security.
About the company
Medistim ASA is a Norway-based company engaged in the provision of medical equipment and technology. It develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The Company provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
- Revenue in NOK (TTM)547.08m
- Net income in NOK101.64m
- Incorporated1995
- Employees152.00
- LocationMedistim ASAOkernveien 94OSLO 0579NorwayNOR
- Phone+47 23059660
- Websitehttps://medistim.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sedana Medical AB (publ) | 177.19m | -58.24m | 1.30bn | 78.00 | -- | 1.34 | -- | 7.34 | -0.5763 | -0.5763 | 1.75 | 9.56 | 0.1697 | 1.16 | 10.14 | 2,204,317.00 | -5.58 | -5.77 | -5.84 | -6.08 | 70.60 | 64.06 | -32.87 | -36.13 | 6.02 | -30.48 | 0.0076 | -- | 25.23 | 21.59 | 18.90 | -- | 42.12 | -- |
| Paxman AB (publ) | 243.04m | 29.14m | 1.37bn | 102.00 | 47.23 | 9.26 | 28.76 | 5.65 | 1.50 | 1.50 | 12.54 | 7.67 | 1.31 | 2.74 | 6.56 | 2,624,791.00 | 15.66 | -5.08 | 20.74 | -7.76 | 70.27 | 69.38 | 11.99 | -5.07 | 1.98 | 12.73 | 0.0838 | -- | 43.99 | 29.35 | 180.69 | -- | 6.26 | -- |
| Nordhealth As | 485.36m | -109.67m | 1.67bn | 355.00 | -- | 3.17 | 97.36 | 3.43 | -1.41 | -1.41 | 6.20 | 11.64 | 0.4329 | -- | 6.73 | 1,228,757.00 | -9.78 | -- | -11.11 | -- | 85.82 | -- | -22.59 | -- | -- | -- | 0.00 | -- | 18.60 | -- | 21.96 | -- | -- | -- |
| Genovis AB | 129.24m | 17.55m | 1.78bn | 37.00 | 101.52 | 8.43 | 60.25 | 13.79 | 0.2635 | 0.2635 | 1.94 | 3.17 | 0.4938 | -- | -- | 3,432,973.00 | 6.71 | 18.56 | 7.21 | 21.45 | 64.41 | 65.51 | 13.58 | 23.88 | -- | 697.00 | 0.2718 | 0.00 | 54.54 | 35.56 | 449.56 | -- | 47.59 | -- |
| Stille AB | 495.96m | 51.75m | 1.95bn | 151.00 | 33.66 | 2.85 | 25.51 | 3.93 | 6.33 | 6.33 | 60.94 | 74.85 | 0.6978 | 2.10 | 8.49 | 4,598,368.00 | 7.28 | 7.03 | 8.70 | 8.19 | 49.17 | 43.93 | 10.43 | 9.85 | 1.12 | 7.41 | 0.00 | 21.98 | 19.70 | 16.78 | -2.48 | 5.34 | 23.62 | -- |
| Detection Technology Oyj | -1.18tn | -1.18tn | 2.40bn | 464.00 | -- | 2.76 | -- | -- | -- | -- | -- | 5.03 | -- | -- | -- | -- | -- | 9.34 | -- | 11.96 | -- | 47.44 | -- | 8.22 | 3.39 | -- | 0.00 | 53.45 | 5.29 | 2.02 | 7.55 | -18.03 | -14.88 | -9.55 |
| Medistim ASA | 547.08m | 101.64m | 2.53bn | 152.00 | 24.87 | 6.24 | 19.98 | 4.63 | 5.55 | 5.55 | 29.87 | 22.12 | 1.13 | 0.7461 | 7.48 | 3,599,204.00 | 21.05 | 22.93 | 25.53 | 28.52 | 79.12 | 78.25 | 18.58 | 20.64 | 2.75 | -- | 0.0181 | 75.25 | 7.00 | 10.06 | -8.91 | 12.72 | 0.033 | 14.87 |
| BICO Group AB | 2.29bn | -800.57m | 2.67bn | 828.00 | -- | 0.9085 | -- | 1.16 | -11.15 | -15.20 | 31.92 | 41.79 | 0.3602 | 2.15 | 4.47 | 2,547,964.00 | -12.62 | -- | -14.44 | -- | 55.70 | -- | -35.03 | -- | 2.23 | -0.5705 | 0.397 | -- | 6.09 | -- | -1,889.33 | -- | -- | -- |
Data as of Nov 12 2024. Currency figures normalised to Medistim ASA's reporting currency: Norwegian Krone NOK
51.64%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Aeternum Management ASas of 27 Sep 2023 | 1.90m | 10.36% |
| SEB Investment Management AB (Denmark)as of 30 Sep 2024 | 1.37m | 7.48% |
| ODIN Forvaltning ASas of 14 Apr 2023 | 1.20m | 6.54% |
| Swedbank Robur Fonder ABas of 30 Sep 2024 | 1.11m | 6.03% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 29 Sep 2023 | 1.01m | 5.49% |
| Invesco Advisers, Inc.as of 30 Sep 2024 | 910.00k | 4.96% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2024 | 627.55k | 3.42% |
| ODIN Forvaltning AS (Sweden)as of 14 Apr 2023 | 600.00k | 3.27% |
| Skandinaviska Enskilda Banken AB (Denmark)as of 30 Sep 2024 | 401.28k | 2.19% |
| Holberg Fondsforvaltning ASas of 14 Apr 2023 | 346.75k | 1.89% |
More ▼
Data from 31 Dec 2023 - 31 Oct 2024Source: FactSet Research Systems Inc.
